Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Prisoners' ambivalent sexism and domestic violence: a narrative study.

Testoni I, Branciforti G, Zamperini A, Zuliani L, Nava FA.

Int J Prison Health. 2019 Dec 5;15(4):332-348. doi: 10.1108/IJPH-09-2018-0046. Epub 2019 Aug 16.

PMID:
31532343
2.

Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinics.

Molinaro S, Resce G, Alberti A, Andreoni M, D Egidio PPF, Leonardi C, Nava FA, Pasqualetti P, Villa S.

Drug Alcohol Rev. 2019 Aug 23. doi: 10.1111/dar.12978. [Epub ahead of print]

PMID:
31441565
3.

Comparison of different conditions for DNA extraction in sputum - a pilot study.

Oriano M, Terranova L, Teri A, Sottotetti S, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Amati F, Nava F, Franceschi E, Cariani L, Blasi F, Aliberti S.

Multidiscip Respir Med. 2019 Jan 31;14:6. doi: 10.1186/s40248-018-0166-z. eCollection 2019.

4.

[Arterial sinus pericranii. First case report].

Nava FB, Barrial M, Triana P, Jiménez J, Amesty V, Miguel M, Díaz M, López Gutiérrez JC.

Cir Pediatr. 2019 Jan 21;32(1):49-52. Spanish.

PMID:
30714702
5.

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.

Stöver H, Meroueh F, Marco A, Keppler K, Saiz de la Hoya P, Littlewood R, Wright N, Nava F, Alam F, Walcher S, Somaini L.

BMC Public Health. 2019 Jan 8;19(1):30. doi: 10.1186/s12889-018-6357-x.

6.

[Slipping rib syndrome in paediatrics: report of 4 cases].

Nava FB, Barrial M, Bret M, Muñoz AJ, Serradilla J, Encinas JL, Martínez L, López-Santamaría M, De la Torre CA.

Cir Pediatr. 2018 Oct 17;31(4):192-195. Spanish.

PMID:
30371032
7.

The Efficacy of Dog Assisted Therapy in Detained Drug Users: A Pilot Study in an Italian Attenuated Custody Institute.

Contalbrigo L, De Santis M, Toson M, Montanaro M, Farina L, Costa A, Nava FA.

Int J Environ Res Public Health. 2017 Jun 24;14(7). pii: E683. doi: 10.3390/ijerph14070683.

8.

Interstitial Lung Disease After Kidney Transplantation and the Role of Everolimus.

Solazzo A, Botta C, Nava F, Baisi A, Bonucchi D, Cappelli G.

Transplant Proc. 2016 Mar;48(2):349-51. doi: 10.1016/j.transproceed.2015.12.039.

PMID:
27109953
9.

Kidney Transplantation in HIV-Infected Recipients: Therapeutic Strategy and Outcomes in Monocentric Experience.

Baisi A, Nava F, Baisi B, Rubbiani E, Guaraldi G, Di Benedetto F, Giovannoni M, Solazzo A, Bonucchi D, Cappelli G.

Transplant Proc. 2016 Mar;48(2):333-6. doi: 10.1016/j.transproceed.2015.12.038.

PMID:
27109949
10.

HIV treatment and care among Italian inmates: a one-month point survey.

Monarca R, Madeddu G, Ranieri R, Carbonara S, Leo G, Sardo M, Choroma F, Casari S, Marri D, Muredda AA, Nava FA, Babudieri S; SIMSPe–SIMIT Group.

BMC Infect Dis. 2015 Dec 10;15:562. doi: 10.1186/s12879-015-1301-5.

11.

Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern.

Michel L, Lions C, Van Malderen S, Schiltz J, Vanderplasschen W, Holm K, Kolind T, Nava F, Weltzien N, Moser A, Jauffret-Roustide M, Maguet O, Carrieri PM, Brentari C, Stöver H.

BMC Public Health. 2015 Oct 27;15:1093. doi: 10.1186/s12889-015-2421-y.

12.

Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome.

Nava F, Ghilotti F, Maggi L, Hatemi G, Del Bianco A, Merlo C, Filippini G, Tramacere I.

Cochrane Database Syst Rev. 2014;(12):CD010729. doi: 10.1002/14651858.CD010729.pub2. Epub 2014 Dec 18. Review.

PMID:
25521793
13.

Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation.

Nava F, Cappelli G, Mori G, Granito M, Magnoni G, Botta C, Solazzo A, Fontana F, Baisi A, Bonucchi D.

Transplant Proc. 2014 Sep;46(7):2263-8. doi: 10.1016/j.transproceed.2014.07.062.

PMID:
25242766
14.

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010.

Nava F, Tramacere I, Fittipaldo A, Bruzzone MG, Dimeco F, Fariselli L, Finocchiaro G, Pollo B, Salmaggi A, Silvani A, Farinotti M, Filippini G.

Neuro Oncol. 2014 May;16(5):719-27. doi: 10.1093/neuonc/not316. Epub 2014 Jan 23.

15.

New frontiers in alcoholism and addiction treatment.

Nava F, Vendramin A, Manzato E, Cibin M, Lucchini A.

Recent Pat CNS Drug Discov. 2010 Jan;5(1):81-94. Review.

PMID:
19751210
16.

Physical activity during the school day in public primary schools in Mexico City.

Jennings-Aburto N, Nava F, Bonvecchio A, Safdie M, González-Casanova I, Gust T, Rivera J.

Salud Publica Mex. 2009 Mar-Apr;51(2):141-7.

PMID:
19377741
17.

Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study.

Nava F, Manzato E, Leonardi C, Lucchini A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1867-72. doi: 10.1016/j.pnpbp.2008.08.019. Epub 2008 Sep 4.

PMID:
18801404
18.

[Facilitators and barriers for the consumption of a micronutrient supplement].

Escalante-Izeta E, Bonvecchio A, Théodore F, Nava F, Villanueva MA, Rivera-Dommarco JA.

Salud Publica Mex. 2008 Jul-Aug;50(4):316-24. Spanish.

PMID:
18670723
19.

Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam.

Nava F, Premi S, Manzato E, Campagnola W, Lucchini A, Gessa GL.

Am J Drug Alcohol Abuse. 2007;33(3):379-92.

PMID:
17613965
20.

Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.

Nava F, Manzato E, Lucchini A.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1089-94. Epub 2007 Mar 30.

PMID:
17466429
21.

Maternal knowledge and use of a micronutrient supplement was improved with a programmatically feasible intervention in Mexico.

Bonvecchio A, Pelto GH, Escalante E, Monterrubio E, Habicht JP, Nava F, Villanueva MA, Safdie M, Rivera JA.

J Nutr. 2007 Feb;137(2):440-6.

PMID:
17237324
22.

Perceived parental monitoring and health risk behavior among public secondary school students in El Salvador.

Springer AE, Sharma S, de Guardado AM, Nava FV, Kelder SH.

ScientificWorldJournal. 2006 Dec 28;6:1810-4.

23.

Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst.

Nava F, Premi S, Manzato E, Lucchini A.

J Psychoactive Drugs. 2006 Sep;38(3):211-7.

PMID:
17165363
24.

Reproductive biology and mating system estimates of two Andean melocacti, Melocactus schatzlii and M. andinus (Cactaceae).

Nassar JM, Ramírez N, Lampo M, González JA, Casado R, Nava F.

Ann Bot. 2007 Jan;99(1):29-38. Epub 2006 Nov 3.

25.
26.

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.

J Neurosci. 2002 Nov 1;22(21):9612-7.

27.

gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors.

Nava F, Carta G, Bortolato M, Gessa GL.

Eur J Pharmacol. 2001 Nov 2;430(2-3):261-3.

PMID:
11711039
28.

An anorexic lipid mediator regulated by feeding.

Rodríguez de Fonseca F, Navarro M, Gómez R, Escuredo L, Nava F, Fu J, Murillo-Rodríguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D.

Nature. 2001 Nov 8;414(6860):209-12.

29.
30.

Melatonin reduces anxiety induced by lipopolysaccharide in the rat.

Nava F, Carta G.

Neurosci Lett. 2001 Jul 6;307(1):57-60.

PMID:
11516574
31.

Cannabinoids: don't use them without a medical prescription!

Nava F.

Trends Pharmacol Sci. 2001 Jan;22(1):13-4. No abstract available.

PMID:
11252259
32.
33.

Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulié P, Piomelli D.

Eur J Pharmacol. 2000 Nov 17;408(2):161-8.

35.

Lipopolysaccharide increases arginine-vasopressin release from rat suprachiasmatic nucleus slice cultures.

Nava F, Carta G, Haynes LW.

Neurosci Lett. 2000 Jul 21;288(3):228-30.

PMID:
10889349
36.

Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats.

Nava F, Carta G, Gessa GL.

Pharmacol Biochem Behav. 2000 May;66(1):183-7.

PMID:
10837859
37.

Dopamine D(2) receptor antagonists prevent delta(9)-tetrahydrocannabinol-induced antinociception in rats.

Carta G, Gessa GL, Nava F.

Eur J Pharmacol. 1999 Nov 19;384(2-3):153-6.

PMID:
10611435
38.

Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs.

Bonina FP, Arenare L, Palagiano F, Saija A, Nava F, Trombetta D, de Caprariis P.

J Pharm Sci. 1999 May;88(5):561-7.

PMID:
10229650
39.

Central effects of cromoglycate sodium salt in rats treated with lipopolysaccharide.

Nava F, Caputi AP.

Eur J Pharmacol. 1999 Feb 19;367(2-3):351-9.

PMID:
10079011
40.
41.

Arrhythmogenic right ventricular dysplasia: pregnancy under flecainide treatment.

Villanova C, Muriago M, Nava F.

G Ital Cardiol. 1998 Jun;28(6):691-3.

PMID:
9672783
42.

Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide.

Cuzzocrea S, Zingarelli B, Sautebin L, Rizzo A, Crisafulli C, Campo GM, Costantino G, Calapai G, Nava F, Di Rosa M, Caputi AP.

Shock. 1997 Oct;8(4):268-75.

PMID:
9329128
43.

Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat.

Nava F, Calapai G, Facciolà G, Cuzzocrea S, Giuliani G, De Sarro A, Caputi AP.

Eur J Pharmacol. 1997 Jul 23;331(2-3):267-74.

PMID:
9274989
44.

Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats.

De Sarro A, Grasso S, Zappala M, Nava F, De Sarro G.

Naunyn Schmiedebergs Arch Pharmacol. 1997 Jul;356(1):48-55.

PMID:
9228189
45.
46.

Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin.

Nava F, Calapai G, Facciolá G, Cuzzocrea S, Marciano MC, De Sarro A, Caputi AP.

Int J Immunopharmacol. 1997 Jan;19(1):31-8.

PMID:
9226477
47.

Interleukin-1 inhibits drinking behaviour through prostaglandins, but not by nitric oxide formation.

Calapai G, Parente L, Nava F, Facciolà G, Marciano MC, Caputi AP.

Life Sci. 1997;60(7):457-64.

PMID:
9042373
48.

Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production.

Cuzzocrea S, Zingarelli B, Calapai G, Nava F, Caputi AP.

Life Sci. 1997;60(3):215-20.

PMID:
9000646
49.

Interleukin-1 receptor antagonist does not reverse lipopolysaccharide-induced inhibition of water intake in rat.

Nava F, Calapai G, De Sarro A, Caputi AP.

Eur J Pharmacol. 1996 Aug 15;309(3):223-7.

PMID:
8874144
50.

Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice.

De Sarro G, Nava F, Aguglia U, De Sarro A.

Neuropharmacology. 1996 Feb;35(2):153-8.

PMID:
8734483

Supplemental Content

Support Center